Mass. Sues J&J Unit Over Risperdal Off-Label Marketing
The Massachusetts attorney general hit a subsidiary of Johnson & Johnson with a lawsuit Monday, accusing the drug company of illegally marketing the antipsychotic drug Risperdal for off-label uses in children...To view the full article, register now.
Already a subscriber? Click here to view full article